[In the Media] “Medical Renaissance: Understanding Rare Diseases (Part 5) – Early Diagnosis: Easing Anxiety and Doubts” (The Yomiuri Shimbun, October 10, 2025)
date : 10/20/2025
A comment by Mr. Ryoji Noritake, Chair, Health and Global Policy Institute (HGPI), was featured in The Yomiuri Shimbun’s Medical Renaissance series, “Understanding Rare Diseases (Part 5) – Early Diagnosis: Easing Anxiety and Doubts,” published on October 10, 2025.
The article discusses the challenges in the diagnosis and support systems for rare and intractable diseases, as well as possible approaches to improve future responses.
For more details, please see the full article here.
*The article is available in Japanese only and requires Yomiuri Shimbun membership for access.
Top Research & Recommendations Posts
- [Research Report] Energy Conservation and Greenhouse Gas Emissions Reduction in Healthcare Facilities: Case Studies from New Construction and Facility Renewal (March 16, 2026)
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Policy Recommendations] Policy Recommendations in the Field of Blood Disorders “Building a Healthcare Ecosystem Centered on Patients and Those Affected” (April 13, 2026)
- [Public Comment Submission] “The 7th Science, Technology and Innovation Basic Plan” (Draft) (February 19, 2026)
- [Research Report] The 2026 Public Opinion Survey on Healthcare in Japan (February 13, 2026)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Research Report] AMR Policy Update #2: WHO’s First Report on Fungal Infection—Bridging the Gap Between Clinical Practice and R&D



